Simulations Plus, Inc. (NASDAQ:SLP) Receives $49.40 Consensus Price Target from Analysts

Simulations Plus, Inc. (NASDAQ:SLP) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $49.40.

A number of equities research analysts have recently issued reports on SLP shares. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. KeyCorp lifted their price objective on Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Friday, January 24th.

Simulations Plus Stock Down 3.1 %

Shares of SLP opened at $24.72 on Friday. The company has a market capitalization of $496.67 million, a PE ratio of 61.80 and a beta of 0.89. Simulations Plus has a 52-week low of $24.00 and a 52-week high of $51.22. The company has a 50-day simple moving average of $31.15 and a 200-day simple moving average of $30.72.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the sale, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 19.40% of the company’s stock.

Institutional Trading of Simulations Plus

A number of hedge funds have recently bought and sold shares of SLP. Public Employees Retirement System of Ohio lifted its stake in shares of Simulations Plus by 58.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 41,692 shares of the technology company’s stock worth $1,163,000 after purchasing an additional 15,399 shares during the period. Millennium Management LLC lifted its position in Simulations Plus by 200.7% during the fourth quarter. Millennium Management LLC now owns 44,841 shares of the technology company’s stock worth $1,251,000 after buying an additional 29,929 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Simulations Plus by 4.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company’s stock worth $254,000 after buying an additional 380 shares during the last quarter. Janus Henderson Group PLC grew its holdings in Simulations Plus by 7,753.3% in the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company’s stock valued at $15,141,000 after buying an additional 535,986 shares during the period. Finally, Deutsche Bank AG increased its stake in shares of Simulations Plus by 52.9% during the 4th quarter. Deutsche Bank AG now owns 14,916 shares of the technology company’s stock valued at $416,000 after acquiring an additional 5,160 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.